182
Participants
Start Date
May 30, 2018
Primary Completion Date
July 31, 2019
Study Completion Date
July 31, 2019
Neridronic acid 100 mg
100 mg neridronic acid supplied in glass vials in 8 mL of excipients.
Placebo
Glass vials with matching placebo.
NZ004 - Optimal Clinical Trials, Grafton
AU002 - Royal North Shore Hospital Michael J Cousins Pain Management and Research Centre, St Leonards
AU005 - Port Kembla Public Hospital, Wollongong
Nz001 - Bay of Plenty Clinical Trials Unit, Bay of Plenty District Health Board, Tauranga
AU003 - Neuro Trials Victoria Pty Ltd, Noble Park
AU001 - The Avenue Cardiovascular Centre Level 1 Masada Private Hospital, St Kilda East
KR007 - Konkuk University Medical Center, Seoul
KR004 - Seoul St Mary's Hospital, Seoul
NZ002 - Southern Clinical Trials Group Ltd, Christchurch
KR006 - Korea University Guro Hospital, Seoul
DE011 - Klinische Forschung Berlin Mitte GmbH, Berlin
ES004 - Hospital Universitario Puerto Real Unidad de Anestesiologia, Puerto Real
US038 - DiGiovanna Institute For Medical Education, North Massapequa
KR003 - Seoul National University Bundang Hospital, Seongnam-si
US029 - Dent Neurologic Institute, Amherst
KR001 - Ajou University Medical Center, Suwon
DE005 - Klinische Forschung Schwerin GmbH, Schwerin
US028 - Founders Research Corporation, Philadelphia
DE002 - Klinische Forschung Hamburg GmbH, Hamburg
US037 - Clinical Research Partners, Richmond
US047 - The Center for Clinical Research, Winston-Salem
ES005 - Hospital Sanitas La Moraleja Pain Unit, Madrid
US022 - The Neurological Institute, Charlotte
US018 - Carolinas Center for Advanced Management of Pain, Spartanburg
US027 - Drug Studies America, Marietta
DE010 - Klinische Forschung Hannover Mitte, Hanover
US041 - Better Health Clinical Research, Inc., Newnan
US012 - NeuroMedical Research Center, Panama City
US007 - Neurology Offices of South Florida, Boca Raton
US023 - AGR Research, Lake Worth
US046 - Clinical Research of West Florida, Inc., Tampa
US030 - Gulfcoast Clinical Research Center, Fort Myers
US020 - SIMEDHealth, Ocala
US004 - The Chappel Group Research, Kissimmee
KR008 - Chungnam National University Hospital, Daejeon
US015 - Tennessee Valley Pain Consultants, Huntsville
US043 - Horizon Research Partners, Mobile
FR001 - Centre Hospitalier Universitaire Grenoble Alpes Centre de la douleur, Grenoble
US009 - Elite Clinical Research, Jackson
US017 - Jackson Anesthesia Pain Center, Jackson
ES006 - Hospital Infanta Luisa Rheumatology, Seville
US011 - Otrimed Corporation, Edgewood
FR002 - L'Hôpital Privé du Confluent Département d'évaluation et traitement de la douleur, Nantes
US005 - Hometown Urgent Care and Research, Dayton
ES007 - Hospital Clínico Universitario de Valencia, Valencia
ES008 - Hospital Lluis Alcanyis Anesthesiology and Pain Unit, Xàtiva
US025 - Oakland Medical Research, Troy
Us054 - Aa Mrc, Flint
DE013 - Klinik und Poliklinik für Neurologie Universitätsmedizin Mainz, Mainz
DE006 - Center for Clinical Research Dr. med. I. Schoel, Bad Homburg
US032 - Millennium Pain Center, Bloomington
US033 - Galen Research, Chesterfield
US003 - HealthStar Research, Hot Springs
US021 - SP Research PLLC, Oklahoma City
US055 - Diversified Medical Practices, Houston
FR004 - Centre Hospitalier Universitaire Amiens Picardie, Amiens
US036 - Denver Back Pain Specialists, Greenwood Village
US048 - Axios Research, Salt Lake City
US045 - Holland Center for Family Health, Peoria
US053 - Core Healthcare Group, Cerritos
US052 - Providere' Research Inc., West Covina
US013 - Inland Pain Medicine, Colton
US044 - The Helm Center for Pain Management, Laguna Woods
US049 - Orange County Research Institute, Anaheim
US040 - Regeneris Medical, North Attleboro
US050 - Premier Pain Centers, Shrewsbury
DE009 - BAG Anästhesie, Schmerztherapie, Palliativmedizin, Cottbus
KR002 - Seoul National University Hospital, Seoul
KR005 - Samsung Medical Center, Seoul
ES009 - General Hospital of Alicante, Alicante
ES002 - Hospital de la Santa Creu i Sant Pau, Barcelona
Lead Sponsor
Grünenthal GmbH
INDUSTRY